Skip to main content
. Author manuscript; available in PMC: 2023 Oct 15.
Published in final edited form as: Am J Cardiol. 2022 Aug 24;181:105–112. doi: 10.1016/j.amjcard.2022.06.064

Figure 2.

Figure 2.

Plasma cell testing in patients with final adjudication of ATTR cardiomyopathy. (A) Pie chart showing the distribution of plasma cell dyscrasia abnormalities. (B) Histogram demonstrating that the majority (69%) of ATTR cardiomyopathy patients had an abnormal FLC ratio between 1.65 and 3.1 and normal IFE.